Skip to main content

PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort

Obiettivo

According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous intervention with coronary stenting and fuelled by the increasing disease burden there has been a rapid increase in the number of percutaneous coronary intervention procedures in Europe from 184,000 in 1992 to 885,000 in 2004. If the rate of progression remains constant, the projected number of coronary intervention procedures per annum will be about 1.5 million by 2010, with a stenting rate of close to 100%. The principal safety issue with current coronary stenting procedures is late stent thrombosis which, with a case mortality rate approaching 50%, makes this problem a very significant European health issue.
The PRESTIGE project will result in significant improvement in prediction and prevention of late stent thrombosis by providing novel strategies that causally impede incident events without increasing the overall risk of bleeding. These goals will be achieved by a multidisciplinary consortium formed by world-leading EU-based specialists covering the requisite scientific skills and experience.
Since the first drug-eluting stent was introduced in 2002 the growth of this sector has been explosive. Forecasts predicted the potential for this market segment to exceed €4.6 billion by 2009. The economic impact of this very ambitious project will be to provide the European health industries with novel stent products and new imaging technologies to identify patients at-risk, as well as amended European treatment guidelines. The social impact will be, amongst others, a tremendous cost reduction for the public and private health insurance systems all over Europe.

Invito a presentare proposte

FP7-HEALTH-2010-single-stage
Vedi altri progetti per questo bando

Coordinatore

DEUTSCHES HERZZENTRUM MUNCHEN
Indirizzo
Lazarettstrasse 36
80636 Munich
Germania
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contributo UE
€ 1 182 400
Contatto amministrativo
Per Larsen (Mr.)

Partecipanti (14)

AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII
Italia
Contributo UE
€ 454 210
Indirizzo
Piazza Oms 1
24127 Bergamo
Tipo di attività
Other
Contatto amministrativo
Giulio Guagliumi (Dr.)
SAMODZIELNY PUBLICZNY ZAKLAD OPIEKI ZDROWOTNEJ SZPITAL UNIWERSYTECKI W KRAKOWIE
Polonia
Contributo UE
€ 58 200
Indirizzo
Ul. Kopernika 36
31 501 Krakow
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contatto amministrativo
Dariusz Dudek (Prof.)
STICHTING SINT ANTONIUS ZIEKENHUIS
Paesi Bassi
Contributo UE
€ 371 620
Indirizzo
Koekoekslaan 1
3435 CM Nieuwegein
Tipo di attività
Research Organisations
Contatto amministrativo
Jurrien Maria Ten Berg (Dr.)
UNIVERSITY OF LEICESTER
United Kingdom
Contributo UE
€ 669 364
Indirizzo
University Road
LE1 7RH Leicester
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Bikramjeet Singh (Mr.)
BENEDIKT-KREUTZ REHABILITATIONSZENTRUM FUER HERZ- UND KREISLAUFKRANKE BAD KROZINGEN EV

Partecipazione conclusa

Germania
Contributo UE
€ 121 200
Indirizzo
Suedring 15
79189 Bad Krozingen
Tipo di attività
Research Organisations
Contatto amministrativo
Christian Valina (Dr.)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Francia
Contributo UE
€ 990 356
Indirizzo
Rue De Tolbiac 101
75654 Paris
Tipo di attività
Research Organisations
Contatto amministrativo
Dina Falkenreck (Ms.)
RIGAS TEHNISKA UNIVERSITATE
Lettonia
Contributo UE
€ 100 755
Indirizzo
Kalku Iela 1
1658 Riga
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Garry Kerch (Dr.)
KITOZYME SA
Belgio
Contributo UE
€ 110 400
Indirizzo
Rue Haute Claire Parc Industriel 4
4040 Herstal
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo
Marie Hobe (Ms.)
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germania
Contributo UE
€ 346 466,50
Indirizzo
Ingolstadter Landstrasse 1
85764 Neuherberg
Tipo di attività
Research Organisations
Contatto amministrativo
Juergen Ertel (Dr.)
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgio
Contributo UE
€ 711 270
Indirizzo
Oude Markt 13
3000 Leuven
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Walter Desmet (Prof.)
SERVICIO MADRILENO DE SALUD
Spagna
Contributo UE
€ 121 440
Indirizzo
Plaza Carlos Trias Bertran 7
28020 Madrid
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contatto amministrativo
Fernando Alfonso (Dr.)
BIOTRONIK SE & CO. KG
Germania
Contributo UE
€ 380 980
Indirizzo
Woermannkehre 1
12359 Berlin
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo
Alexander Rzany (Dr.)
NEOPLAS GMBH
Germania
Contributo UE
€ 360 980
Indirizzo
Walther Rathenau Strasse 49A
17489 Greifswald
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo
Renate Schönebeck (Ms.)
UNIVERSITATS-HERZZENTRUM FREIBURG-BAD KROZINGEN GMBH
Germania
Indirizzo
Sudring 15
79189 Bad Krozingen
Tipo di attività
Research Organisations
Contatto amministrativo
Gerhard Henninger (Mr.)